Actively Recruiting
Community-based Evaluation of a Novel, System-wide Harm Reduction Strategic Plan for People Experiencing Homelessness in New York City
Led by NYU Langone Health · Updated on 2025-09-12
80
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
N
NYU Langone Health
Lead Sponsor
C
Centers for Disease Control and Prevention
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to evaluate the effects of harm reduction initiatives on overdose and other health outcomes among people experiencing homelessness in New York City shelters. The study uses mixed methods, including analysis of administrative homeless services and Medicaid data, as well as in-depth interviews and focus groups. It focuses on the implementation and impact of a Harm Reduction Strategic Plan (HRSP) within the NYC single-adult shelter system. The study involves analyzing data from individuals in the NYC single-adult homeless services system from 2021 to 2026. It also conducts qualitative interviews and focus groups with homeless services providers, administrators, clients who have received HRSP interventions, and stakeholders involved in planning and implementing these interventions. These activities aim to capture diverse perspectives on the HRSP's effects. Participants' involvement includes data analysis without direct contact for some aims, and interviews or focus groups for others. Researchers will assess outcomes such as the incidence of fatal and non-fatal overdoses, substance use disorder treatment initiation, and health services use. The study will monitor these measures using administrative data, while qualitative sessions explore personal experiences. The total study period spans several years, allowing for comprehensive evaluation over time.
CONDITIONS
Brief Title
Shelter HArm Reduction Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- For Aims 1a, 1b, and 2: Records included for individuals aged 18 or older in the NYC single-adult shelter system during 2021-2026 and matched Medicaid comparison group.
- For Aim 3 Homeless Services Client group: Adults 18 years or older who speak English, stayed in NYC single-adult shelters with HRSP interventions, report past-year drug use, and can provide consent.
- For Aim 3 Homeless Services Staff group: Adults 18 years or older who speak English, work at shelters with HRSP interventions, and can provide consent.
- For Aim 3 Homeless Services Stakeholder group: Adults 18 years or older who speak English, work in roles with key insight into HRSP interventions including planning and implementation, and can provide consent.
You will not qualify if you...
- Under 18 years of age for all aims.
- For Aim 3: Currently a prisoner, unable to communicate in English, or unable to provide informed consent.
- For Aim 3 Homeless Services Client group: Those who have not stayed at shelters with HRSP interventions or do not report past-year drug use.
- For Aim 3 Homeless Services Staff group: Those not employed at shelters with HRSP interventions.
- Additional exclusion may apply to ensure diverse participant experiences in qualitative interviews.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for qualitative interview consent and eligibility assessment
Duration - Up to 5 years (2021-2026)
Participants' administrative data on shelter usage, health services, and overdose events are analyzed for the years 2021 to 2026.
No visits required; data collected from existing administrative and Medicaid records
Duration - Varies by participant, typically one or more sessions over several weeks
Participants take part in in-depth interviews and focus groups to share their experiences with the Harm Reduction Strategic Plan interventions.
1 to 3 visits (in-person or remote) for interviews and focus groups depending on participant group
Trial Site Locations
Total: 1 location
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
Research Team
B
Bennett Allen, PhD
K
Kelly Doran, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here